OLFML3 also acts as a vascular tissue remodeler with pro-angiogenic properties by modulating critical signaling circuits such as Notch pathways (Tomarev and Nakaya, 2009), which underlies inflammation and pathology in RA (Wei et al., 2020). Here, OLFML3 is linked to rheumatoid arthritis.